Compare JCI & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JCI | BDX |
|---|---|---|
| Founded | 1885 | 1897 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.1B | 55.5B |
| IPO Year | N/A | 1962 |
| Metric | JCI | BDX |
|---|---|---|
| Price | $138.74 | $176.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $132.54 | ★ $189.60 |
| AVG Volume (30 Days) | ★ 5.3M | 2.7M |
| Earning Date | 02-04-2026 | 02-09-2026 |
| Dividend Yield | 1.15% | ★ 2.39% |
| EPS Growth | ★ 102.80 | 3.08 |
| EPS | 5.29 | ★ 6.12 |
| Revenue | ★ $23,967,000,000.00 | $21,924,000,000.00 |
| Revenue This Year | $6.43 | $3.16 |
| Revenue Next Year | $5.49 | $3.12 |
| P/E Ratio | $46.83 | ★ $28.72 |
| Revenue Growth | 3.44 | ★ 6.22 |
| 52 Week Low | $68.03 | $162.29 |
| 52 Week High | $143.17 | $235.34 |
| Indicator | JCI | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 77.53 | 32.53 |
| Support Level | $118.41 | $164.41 |
| Resistance Level | $143.17 | $182.75 |
| Average True Range (ATR) | 3.40 | 6.17 |
| MACD | 1.83 | -3.75 |
| Stochastic Oscillator | 85.95 | 23.59 |
Johnson Controls International PLC is engaged in engineering, manufacturing, commissioning and retrofitting building products and systems, including commercial HVAC equipment, industrial refrigeration systems, controls, security systems, fire-detection systems and fire-suppression solutions. It sells and installs its commercial HVAC equipment and systems, control systems, security systems, fire-detection and fire suppression systems, equipment and services through its extensive direct channel. The company's geographical segments include Americas, EMEA, and APAC. The company generates the majority of its revenue from the sales of its Products & Systems in the Americas.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.